Pitavastatin
Nikita (pitavastatin) is a small molecule pharmaceutical. Pitavastatin was first approved as Nikita on 2017-08-04. It is used to treat hypercholesterolemia, hyperlipoproteinemias, and hypertriglyceridemia in the USA. It is known to target 3-hydroxy-3-methylglutaryl-Coenzyme A reductase.
| Trade Name | Nikita |
|---|---|
| Common Name | Pitavastatin |
| Indication | hypercholesterolemia, hyperlipoproteinemias, hypertriglyceridemia |
| Drug Class | Enzyme inhibitors: antihyperlipidemics (HMG-CoA inhibitors) |
